<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Liu Y</submitter><funding>Wu Jieping Medical Foundation</funding><funding>Natural Science Foundation of Shanghai</funding><pubmed_abstract>Interleukin (IL)-35-secreting B (IL-35+B) cells are critical regulators in autoimmune and infectious diseases and exert suppressive functions in parallel with IL-10-producing B (B10) cells. However, the role of IL-35+B cells in persistent hepatitis B virus (HBV) infection remains unclear. To elucidate the role of IL-35+B cells in the progress of chronic HBV infection, we determined the frequency of IL-35+B cells and their relationship with the classical human regulatory B cell (Breg) subsets, namely, CD19+CD24&lt;sup>hi&lt;/sup>CD38&lt;sup>hi&lt;/sup> and CD19+CD24&lt;sup>hi&lt;/sup>CD27+. Then, the regulatory effect and mechanism of Bregs on effector T cells were investigated &lt;i>in vitro&lt;/i>. Here, we found that compared with healthy controls, the frequency of IL-35+B cells was increased in patients with c</pubmed_abstract><journal>Frontiers in immunology</journal><pagination>653198</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8072152</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Regulatory B Cells Dysregulated T Cell Function in an IL-35-Dependent Way in Patients With Chronic Hepatitis B.</pubmed_title><pmcid>PMC8072152</pmcid><pubmed_authors>Tian Z</pubmed_authors><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Liang X</pubmed_authors><pubmed_authors>Luo Y</pubmed_authors><pubmed_authors>Jiang M</pubmed_authors><pubmed_authors>Tang G</pubmed_authors><pubmed_authors>Zhu T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Regulatory B Cells Dysregulated T Cell Function in an IL-35-Dependent Way in Patients With Chronic Hepatitis B.</name><description>Interleukin (IL)-35-secreting B (IL-35+B) cells are critical regulators in autoimmune and infectious diseases and exert suppressive functions in parallel with IL-10-producing B (B10) cells. However, the role of IL-35+B cells in persistent hepatitis B virus (HBV) infection remains unclear. To elucidate the role of IL-35+B cells in the progress of chronic HBV infection, we determined the frequency of IL-35+B cells and their relationship with the classical human regulatory B cell (Breg) subsets, namely, CD19+CD24&lt;sup>hi&lt;/sup>CD38&lt;sup>hi&lt;/sup> and CD19+CD24&lt;sup>hi&lt;/sup>CD27+. Then, the regulatory effect and mechanism of Bregs on effector T cells were investigated &lt;i>in vitro&lt;/i>. Here, we found that compared with healthy controls, the frequency of IL-35+B cells was increased in patients with c</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2026-05-03T09:06:10.866Z</modification><creation>2022-02-10T08:21:47.739Z</creation></dates><accession>S-EPMC8072152</accession><cross_references><pubmed>33912178</pubmed><doi>10.3389/fimmu.2021.653198</doi></cross_references></HashMap>